Ultragenyx Pharmaceutical Total Long-Term Assets 2012-2024 | RARE
Ultragenyx Pharmaceutical total long-term assets for the quarter ending June 30, 2024 were $0.654B, a 7.33% increase year-over-year.
- Ultragenyx Pharmaceutical total long-term assets for 2023 were $0.759B, a 14.71% increase from 2022.
- Ultragenyx Pharmaceutical total long-term assets for 2022 were $0.662B, a 0.64% decline from 2021.
- Ultragenyx Pharmaceutical total long-term assets for 2021 were $0.666B, a 43.41% increase from 2020.